Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has issued an announcement.
Jiangsu Recbio Technology Co., Ltd. has announced an extraordinary general meeting scheduled for December 19, 2025, to discuss significant corporate governance changes, including the abolishment of the Supervisory Board and amendments to the Articles of Association. The meeting will also address the election of new directors and amendments to management rules, potentially impacting the company’s governance structure and operational strategies.
The most recent analyst rating on (HK:2179) stock is a Sell with a HK$5.50 price target. To see the full list of analyst forecasts on Jiangsu Recbio Technology Co., Ltd. Class H stock, see the HK:2179 Stock Forecast page.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on biotechnology and medical technology advancements.
Average Trading Volume: 39,478
Technical Sentiment Signal: Sell
Current Market Cap: HK$2.69B
See more data about 2179 stock on TipRanks’ Stock Analysis page.